Alaunos Therapeutics, Inc. (TCRT) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 11, 2026 filed Aug. 6, 2026 | Weis Holger CEO | $8,770 | 4,363 | +21% | No | |
|
|
||||||
| July 27, 2026 filed July 23, 2026 | Jerman Michael Allen Director | $15,625 | 8,138 | +52% | No | |
|
|
||||||
| July 27, 2026 filed July 23, 2026 | Weis Holger CEO | $8,771 | 4,568 | +28% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Weis Holger Chief Executive Officer | $8,769 | 3,880 | +31% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free